Sarasota, FL, United States of America

Daniel Paris

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Tampa, FL (US) (2009)
  • Wesley Chapel, FL (US) (2009)
  • Bradenton, FL (US) (2010)
  • Sarasota, FL (US) (2011 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Daniel Paris**

Introduction

Daniel Paris, an inventive force based in Sarasota, FL, has made significant contributions to the field of pharmaceuticals with a total of seven patents under his name. His groundbreaking work primarily focuses on addressing neurodegenerative diseases, particularly Alzheimer's disease, reflecting his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among Daniel Paris's most notable recent patents are a pharmaceutical composition that combines therapeutic alkaloids with non-alkaloid components to enhance efficacy in treatments. Another important patent details a method for reducing amyloid deposition, neurotoxicity, and microgliosis associated with Alzheimer's disease through the administration of the (R)-enantiomer of nilvadipine. This innovative approach not only targets Alzheimer's but also offers solutions for reducing risks associated with traumatic brain injuries, showcasing his versatility in addressing critical health issues.

Career Highlights

Throughout his career, Daniel has made significant strides in pharmaceutical research. He has worked with prominent organizations, including the Alzheimer's Institute of America, Inc. and Roskamp Research LLC. His dedication to developing effective treatments for neurodegenerative conditions has been evident in the impactful work produced during his tenure at these institutions.

Collaborations

Daniel Paris has collaborated with esteemed colleagues in the research community, including Michael J. Mullan and Robert A. Ivey, III. These partnerships have contributed to his progress and enhanced the scope of his research, forging new pathways in the understanding and treatment of brain diseases.

Conclusion

Daniel Paris exemplifies the spirit of innovation through his meaningful contributions to the pharmaceutical industry. As he continues to develop new methodologies for treating challenging health conditions, his work remains vital to fostering advancements in the medical field and improving the lives of those affected by debilitating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…